ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan

Irinotecan is a key drug for patients with advanced and recurrent colorectal carcinoma. However, the efficacy of irinotecan is not sufficient; partly, as there is no useful marker to predict chemosensitivity to the drug. The aim of the present study was to evaluate whether the expression levels of a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: Tuy, Hoang Dinh, Shiomi, Hisanori, Mukaisho, Ken Ichi, Naka, Shigeyuki, Shimizu, Tomoharu, Sonoda, Hiromichi, Mekata, Eiji, Endo, Yoshihiro, Kurumi, Yoshimasa, Sugihara, Hiroyuki, Tani, Masaji, Tani, Tohru
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038226/
https://ncbi.nlm.nih.gov/pubmed/27698852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4937
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires